Data / Drug companies / Azithromycin
Azithromycin: 41 companies and 139 products in the FDA NDC directory
Azithromycin is listed in the FDA National Drug Code Directory by 41 companies, with 139 products in commercial distribution. 139 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; powder, for suspension; suspension, and the newest product started marketing on October 28, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 41
- Products
- 139
- Generic (ANDA) products
- 139 (100.0%)
- Application numbers
- 26
- Routes
- Oral, Parenteral, Intravenous
- openFDA record search
- api.fda.gov
Companies that list azithromycin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 15 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | January 16, 2026 |
| NuCare Pharmaceuticals,Inc. | 13 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | March 12, 2019 |
| Proficient Rx LP | 9 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | March 12, 2019 |
| Preferred Pharmaceuticals Inc. | 7 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | June 27, 2024 |
| Remedyrepack Inc. | 7 | tablet, film coated | Generic drugs (ANDA) | June 20, 2025 |
| Direct_Rx | 5 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | January 12, 2022 |
| Asclemed USA, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | April 11, 2022 |
| Epic Pharma, LLC | 4 | powder, for suspension | Generic drugs (ANDA) | April 10, 2018 |
| Zhejiang Poly Pharm. Co., Ltd. | 4 | powder, for suspension | Generic drugs (ANDA) | April 11, 2025 |
| Zydus Lifesciences Limited | 4 | powder, for suspension | Generic drugs (ANDA) | August 6, 2018 |
| Zydus Pharmaceuticals USA Inc. | 4 | powder, for suspension | Generic drugs (ANDA) | August 6, 2018 |
| Alembic Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | January 29, 2020 |
| Alembic Pharmaceuticals Limited | 3 | tablet, film coated | Generic drugs (ANDA) | January 29, 2020 |
| AvKARE | 3 | tablet, film coated | Generic drugs (ANDA) | April 24, 2024 |
| Bionpharma Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | March 12, 2019 |
| Lupin Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | November 17, 2022 |
| Proficient Rx LP | 3 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | December 17, 2010 |
| Puracap Laboratories LLC DBA Blu Pharmaceuticals | 3 | powder, for suspension | Generic drugs (ANDA) | May 30, 2025 |
| Sandoz Inc | 3 | tablet, film coated | Generic drugs (ANDA) | November 14, 2005 |
| Sportpharm LLC | 3 | tablet, film coated | Generic drugs (ANDA) | January 6, 2006 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | January 6, 2006 |
| AiPing Pharmaceutical, Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | January 16, 2026 |
| American Health Packaging | 2 | tablet, film coated | Generic drugs (ANDA) | August 1, 2023 |
| Aurobindo Pharma Limited | 2 | powder, for suspension | Generic drugs (ANDA) | October 9, 2018 |
| Aurobindo Pharma Limited | 2 | tablet, film coated | Generic drugs (ANDA) | July 5, 2018 |
| Bryant Ranch Prepack | 2 | tablet, film coated | Generic drugs (ANDA) | July 5, 2018 |
| Chartwell RX, LLC | 2 | suspension | Generic drugs (ANDA) | May 15, 2015 |
| Coupler LLC | 2 | tablet, film coated | Generic drugs (ANDA) | October 28, 2026 |
| Lannett Company, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 4, 2019 |
| Major Pharmaceuticals | 2 | tablet, film coated | Generic drugs (ANDA) | May 1, 2023 |
| Redpharm Drug | 2 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | August 6, 2018 |
| Rising Pharma Holdings, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | June 3, 2026 |
| State Health Services, Texas Department of | 2 | powder, for suspension | Generic drugs (ANDA) | December 28, 2010 |
| Teva Pharmaceuticals USA, Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | December 28, 2010 |
| Advanced Rx of Tennessee, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | January 9, 2023 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | July 5, 2018 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | March 12, 2019 |
| Cardinal Health 107, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | July 2, 2024 |
| Doc Rx | 1 | tablet, film coated | Generic drugs (ANDA) | March 12, 2019 |
| Eugia US LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 19, 2015 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | November 17, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 88 | 63.3% |
| Powder, for suspension | 48 | 34.5% |
| Suspension | 2 | 1.4% |
| Injection, powder, lyophilized, for solution | 1 | 0.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 139 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Macrolide Antimicrobial | 139 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.